| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.026 | 0.9 |